Post-herpetic neuralgia is persistent nerve pain in an area previously affected by shingles. Burning, stabbing pain or sensitivity to light touch can continue after the rash has healed. Symptoms and recovery vary, and the pain may interfere with sleep, clothing and ordinary activity. [1]
Assessment and daily impact
A clinician reviews the shingles episode, the distribution and character of pain, skin changes and other possible causes. Explain whether touch, temperature or movement aggravates symptoms and how pain affects sleep and function. A new rash or new neurological symptom deserves reassessment rather than being assumed to be the old condition. [1] [3]
Bring a list of medicines and previous treatments. Age, kidney function, falls risk and other health conditions can affect which options are suitable.
What treatments may help?
Selected medicines used for nerve pain may include a tricyclic antidepressant, duloxetine, gabapentin or pregabalin. The choice and dose require individual assessment. Treatment is often adjusted gradually and reviewed for pain, sleep, function and side effects. Do not start, stop or change these medicines solely from a website. [2]
Local treatments, including suitable topical medicines, may help some people with a small sensitive area. Practical measures such as comfortable clothing and support for sleep can also matter. The aim is meaningful improvement; no medicine reliably eliminates pain for everyone. [1] [2]
Persistent severe pain may warrant specialist review. Any proposed injection or other intervention should have an explanation of the evidence for post-herpetic neuralgia, expected benefit, alternatives and risks, rather than a promise to reset the affected nerve.
When shingles needs prompt treatment
A new shingles rash should be assessed promptly because early treatment may be important. Shingles involving the eye or nose, a change in vision, or shingles in someone with a weakened immune system needs urgent advice. [3]
Vaccination is a preventive discussion for eligible adults; it does not treat established post-herpetic neuralgia. Ask your clinician about suitability and current local recommendations rather than assume that a previous episode removes future risk. [3]
Questions to ask
What improvement would justify continuing this medicine? Which side effects should I report? When will treatment be reviewed, and what is the plan if the first option does not help?
Related information
Sources and evidence
Evidence sources checked: 10 November 2026. This information supports a clinical discussion; diagnosis and treatment depend on an individual assessment.